NCT07862933Recruiting
AI-Based Conversational Social Support for Older Adults With Heart Failure
Gendered Psychosocial Pathways of Social Frailty in Older Adults With Heart Failure: A Longitudinal Study of an AI-Based Conversational Social-Support Intervention.
Source: ClinicalTrials.gov · Last updated 16 Oct 2026
Brief summary (registry, in English)
This three-year study aims to investigate gender differences in social frailty and evaluate the effects of an artificial intelligence (AI)-based conversational social-support intervention among older adults with chronic heart failure (CHF). The study plans to enroll 300-500 adults aged 60 years or older from four Chang Gung Memorial Hospital branches in Taiwan. In the first phase, researchers will assess participants' clinical characteristics, sarcopenia, physical activity, and physical, psychological, and social frailty. The study will examine gender differences and identify factors associated with social frailty. In the second phase, 174 participants are planned to be assigned to three groups: an AI-based conversational social-support group, a community social participation group, and a control group. The AI group will engage in daily 15-30-minute app-based conversations, while the community group will be encouraged to participate in regular social activities. The control group will maintain routine activities. The third phase will assess longer-term changes in social frailty, emotional well-being, physical activity, and health outcomes, with follow-up assessments at 1, 3, 6, and 12 months after the intervention.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 174 (estimated)
- First submitted
- 1 Oct 2026
- Start date
- Nov 2025
- Primary completion date
- Jul 2028
- Lead sponsor
- Chang Gung University of Science and Technology
- Diseases
- Heart failure
- NCT number
- NCT07862933
What you commit to
- Study type: Interventional
- Planned participants: 174
- From Nov 2025 to the primary completion date, Jul 2028
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Unstable heart failure.
- Severe comorbidities, such as end-stage renal disease, advanced hepatic dysfunction, or terminal malignancies.
- Active psychiatric conditions, including major depression or psychosis, that could interfere with study participation or adherence.
Other
- Severe cognitive deficits that impede the ability to provide informed consent or participate in study interventions.
- Uncorrected visual or hearing impairments that hinder effective communication or interaction with the AI-based conversational social-support intervention.
Who the study is looking for
- Participants aged 60 years or older.
- Diagnosis of chronic heart failure (CHF).
- Ability to communicate effectively in Mandarin or Taiwanese.
Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| New Taipei Municipal Tucheng Hospital (Built and Operated by Chang Gung Medical Foundation) Coordinator of this site? Confirm its status | New Taipei City | Taiwan | Recruiting |
| Chang Gung Memorial Hospital, Linkou Coordinator of this site? Confirm its status | Taoyuan | Taiwan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.